Skip to main content
ConductScienceScienceDex

Juan Enrique Rozengurt

From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #13,841
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6774619Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology

NIH Funding · FY2026

Linked Award Amount
$1.4M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#13,841
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Juan Enrique Rozengurt. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Juan Enrique Rozengurt as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI135201-08R01Co-investigator
    The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection
    University of California, Los Angeles · Pathology (NIH department code)
    $733.8K
    award amount
  • 5R01AI173050-04R01Co-investigator
    Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
    University of California, Los Angeles · Pathology (NIH department code)
    $710.7K
    award amount

Award organization

Organizations that administered FY2026 awards listing Juan Enrique Rozengurt as a PI.

FY2026 award administered by University of California, Los Angeles (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, Los Angeles
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6857
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Juan Enrique Rozengurt.

Elaine F Reed
University of California, Los Angeles
6
shared awards
Robert L Fairchild
University of California, Los Angeles
6
shared awards
Guido Erwin Michael Eibl
University of California, Los Angeles
1
shared award
Stephen J. Pandol
University of California, Los Angeles
1
shared award
Vay Liang W Go
University of California, Los Angeles
1
shared award

Explore further

Find collaborators for Juan Enrique Rozengurt

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →